{
  "input": {
    "mode": "score",
    "query": {
      "entity": "Epileptic encephalopathy",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_clobazam",
          "name": "Clobazam"
        }
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_lacosamide",
          "name": "Lacosamide"
        }
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_levetiracetam",
          "name": "Levetiracetam"
        }
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_lamotrigine",
          "name": "Lamotrigine"
        }
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_topiramate",
          "name": "Topiramate"
        }
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_valproate",
          "name": "Valproate"
        }
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_zonisamide",
          "name": "Zonisamide"
        }
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_rufinamide",
          "name": "Rufinamide"
        }
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_perampanel",
          "name": "Perampanel"
        }
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_carbamazepine",
          "name": "Carbamazepine"
        }
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_eslicarbazepine",
          "name": "Eslicarbazepine"
        }
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_phenobarbital",
          "name": "Phenobarbital"
        }
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_clobazam",
          "type": "Drug",
          "label": "Clobazam",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lacosamide",
          "type": "Drug",
          "label": "Lacosamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_levetiracetam",
          "type": "Drug",
          "label": "Levetiracetam",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lamotrigine",
          "type": "Drug",
          "label": "Lamotrigine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_topiramate",
          "type": "Drug",
          "label": "Topiramate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_valproate",
          "type": "Drug",
          "label": "Valproate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_zonisamide",
          "type": "Drug",
          "label": "Zonisamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rufinamide",
          "type": "Drug",
          "label": "Rufinamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_perampanel",
          "type": "Drug",
          "label": "Perampanel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_carbamazepine",
          "type": "Drug",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_eslicarbazepine",
          "type": "Drug",
          "label": "Eslicarbazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_phenobarbital",
          "type": "Drug",
          "label": "Phenobarbital",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "epileptic_encephalopathy",
          "type": "Disease",
          "label": "Epileptic encephalopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_GABA_A_receptor",
          "type": "Target",
          "label": "GABA_A receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_GABAergic_pathway",
          "type": "Pathway",
          "label": "GABAergic signaling pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pheno_dosage_response",
          "type": "Phenotype",
          "label": "Dosage response curve",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "claim_efficacy",
          "type": "Claim",
          "label": "Efficacy in treating Epileptic encephalopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_clobazam",
          "type": "Target",
          "label": "OffTargetClobazam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_clobazam",
          "type": "Pathway",
          "label": "RiskPathwayClobazam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_clobazam",
          "type": "Phenotype",
          "label": "AdversePhenotypeClobazam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lacosamide",
          "type": "Target",
          "label": "OffTargetLacosamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_lacosamide",
          "type": "Pathway",
          "label": "RiskPathwayLacosamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_lacosamide",
          "type": "Phenotype",
          "label": "AdversePhenotypeLacosamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_levetiracetam",
          "type": "Target",
          "label": "OffTargetLevetiracetam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_levetiracetam",
          "type": "Pathway",
          "label": "RiskPathwayLevetiracetam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_levetiracetam",
          "type": "Phenotype",
          "label": "AdversePhenotypeLevetiracetam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Clobazam",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Lacosamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Levetiracetam",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Lamotrigine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Topiramate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Valproate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Zonisamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Rufinamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Perampanel",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Eslicarbazepine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Phenobarbital",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_clobazam",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知GABA_A受体激动剂"
        },
        {
          "source": "drug_lacosamide",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响GABA的释放"
        },
        {
          "source": "drug_levetiracetam",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "有助于GABA的调节"
        },
        {
          "source": "drug_lamotrigine",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响离子通道与GABA通路"
        },
        {
          "source": "drug_topiramate",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "增强GABA作用的已知机制"
        },
        {
          "source": "drug_valproate",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "强GABA_A受体增强剂"
        },
        {
          "source": "drug_zonisamide",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响GABA合成与释放"
        },
        {
          "source": "drug_rufinamide",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "调节GABA作用的机理"
        },
        {
          "source": "drug_perampanel",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "在试验中显示与GABA介导的路径相关"
        },
        {
          "source": "drug_carbamazepine",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "调节GABA的作用"
        },
        {
          "source": "drug_eslicarbazepine",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "影响GABA通路的药物"
        },
        {
          "source": "drug_phenobarbital",
          "target": "target_GABA_A_receptor",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知的GABA_A介导药物"
        },
        {
          "source": "target_GABA_A_receptor",
          "target": "pathway_GABAergic_pathway",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "参与GABA通路"
        },
        {
          "source": "pathway_GABAergic_pathway",
          "target": "epileptic_encephalopathy",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "GABA通路相关于癫痫发作"
        },
        {
          "source": "drug_clobazam",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "强支持癫痫性脑病效果"
        },
        {
          "source": "drug_lacosamide",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "临床数据支持"
        },
        {
          "source": "drug_levetiracetam",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "广泛用于癫痫性脑病"
        },
        {
          "source": "drug_lamotrigine",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "支持临床有效性"
        },
        {
          "source": "drug_topiramate",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "临床研究证实"
        },
        {
          "source": "drug_valproate",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "很高的疗效证据"
        },
        {
          "source": "drug_zonisamide",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "部分临床数据支持"
        },
        {
          "source": "drug_rufinamide",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于难治性病例"
        },
        {
          "source": "drug_perampanel",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "初步证据支持"
        },
        {
          "source": "drug_carbamazepine",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "作用机制与癫痫相关"
        },
        {
          "source": "drug_eslicarbazepine",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "与癫痫药物机制一致"
        },
        {
          "source": "drug_phenobarbital",
          "target": "claim_efficacy",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "应用于癫痫的老药"
        },
        {
          "source": "claim_efficacy",
          "target": "epileptic_encephalopathy",
          "relation": "entails",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "明确表明治疗作用"
        },
        {
          "source": "drug_clobazam",
          "target": "n_ot_clobazam",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的旁路作用"
        },
        {
          "source": "n_ot_clobazam",
          "target": "n_rp_clobazam",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险链路"
        },
        {
          "source": "n_rp_clobazam",
          "target": "n_adv_clobazam",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_adv_clobazam",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消药物效益"
        },
        {
          "source": "drug_lacosamide",
          "target": "n_ot_lacosamide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的旁路作用"
        },
        {
          "source": "n_ot_lacosamide",
          "target": "n_rp_lacosamide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险链路"
        },
        {
          "source": "n_rp_lacosamide",
          "target": "n_adv_lacosamide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_adv_lacosamide",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消药物效益"
        },
        {
          "source": "drug_levetiracetam",
          "target": "n_ot_levetiracetam",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在可能的旁路作用"
        },
        {
          "source": "n_ot_levetiracetam",
          "target": "n_rp_levetiracetam",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险链路"
        },
        {
          "source": "n_rp_levetiracetam",
          "target": "n_adv_levetiracetam",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_adv_levetiracetam",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消药物效益"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.66,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.7,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.6
          },
          "graph_signals": {
            "support_weight": 1.7,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Clobazam efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_clobazam"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Clobazam acts on GABA_A receptor, involved in GABAergic signaling pathway."
            ],
            "safety_risk": [
              "Skeptic points to significant adverse effects considering off-target actions."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Long-term effects of Clobazam and its potential hindrance to efficacy need further investigation."
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.64,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.65,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.6
          },
          "graph_signals": {
            "support_weight": 1.65,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Lacosamide efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_lacosamide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Lacosamide influences GABA release, involved in GABAergic pathway."
            ],
            "safety_risk": [
              "Skeptic highlights potential adverse effects that may reduce its therapeutic efficacy."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Need further evidence on Lacosamide's long-term safety and its risk profile."
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.62,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.65,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.6
          },
          "graph_signals": {
            "support_weight": 1.6,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Levetiracetam efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_levetiracetam"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Levetiracetam is known for modulating GABA, acting on GABA_A receptor."
            ],
            "safety_risk": [
              "Skeptic notes potential adverse effects that may compromise therapeutic benefits."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Further validation needed on long-term effects and safety profile."
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.6,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.25,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.7
          },
          "graph_signals": {
            "support_weight": 1.55,
            "contradiction_weight": 1.6,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Lamotrigine efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_lamotrigine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Lamotrigine affects ion channels that interact with GABA pathways."
            ],
            "safety_risk": [
              "Skeptic indicates there may be risks that counteract its benefits."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Safety profile still requires adequate assessment."
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.55,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.7
          },
          "graph_signals": {
            "support_weight": 1.5,
            "contradiction_weight": 1.6,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Topiramate efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_topiramate"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Topiramate enhances GABA_A receptor functionality."
            ],
            "safety_risk": [
              "Skeptic highlights potential adverse reactions affecting its utility."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Further investigation is required regarding side effects."
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.8,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.75,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 1.9,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Valproate is a potent GABA_A receptor enhancer."
            ],
            "safety_risk": []
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.56,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.7
          },
          "graph_signals": {
            "support_weight": 1.4,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Zonisamide efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_zonisamide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Zonisamide affects GABA signaling."
            ],
            "safety_risk": [
              "Skeptic raises potential adverse event risks that complicate its efficacy."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Insufficient long-term data on Zonisamide's safety."
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.7
          },
          "graph_signals": {
            "support_weight": 1.3,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Rufinamide efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_rufinamide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Rufinamide modulates GABA channels."
            ],
            "safety_risk": [
              "Skeptic notes adverse effects alignment that impedes efficacy."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Rufinamide's full safety profile requires more data."
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.52,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.45,
            "indication_plausibility": 0.45,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 1.2,
            "contradiction_weight": 1.6,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Perampanel efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_perampanel"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Perampanel acts indirectly on GABA pathways."
            ],
            "safety_risk": [
              "Skeptic emphasizes existence of adverse reactions that could nullify benefits."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Lack of comprehensive safety assessment for Perampanel."
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.5,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.45,
            "indication_plausibility": 0.45,
            "safety_risk": 0.4,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 1.0,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Carbamazepine efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_carbamazepine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Carbamazepine interacts with GABA_A signaling."
            ],
            "safety_risk": [
              "Skeptic outlines possible side effects that could counteract its efficacy."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Inconsistencies in evidence regarding Carbamazepine's safety and efficacy."
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.48,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.45,
            "safety_risk": 0.4,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Eslicarbazepine efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_eslicarbazepine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Eslicarbazepine has some action on GABA pathways."
            ],
            "safety_risk": [
              "Skeptic points to adverse effects that may jeopardize treatment outcomes."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Need better clarity on the risk-benefit ratio."
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.46,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.45,
            "safety_risk": 0.4,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.8
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 1.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Phenobarbital efficacy vs. adverse effects",
                "pro": [
                  "claim_efficacy"
                ],
                "con": [
                  "n_adv_phenobarbital"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Phenobarbital is believed to generally enhance GABA activity."
            ],
            "safety_risk": [
              "Skeptic underscores potential adverse events that could limit effectiveness."
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "Further research is needed to fully outline its feasibility."
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "scoring_summary": [
      {
        "hypothesis_id": "H1",
        "score": 0.66,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.2,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.6
        },
        "graph_signals": {
          "support_weight": 1.7,
          "contradiction_weight": 1.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Clobazam efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_clobazam"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Clobazam acts on GABA_A receptor, involved in GABAergic signaling pathway."
          ],
          "safety_risk": [
            "Skeptic points to significant adverse effects considering off-target actions."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Long-term effects of Clobazam and its potential hindrance to efficacy need further investigation."
        ]
      },
      {
        "hypothesis_id": "H2",
        "score": 0.64,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.65,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.6
        },
        "graph_signals": {
          "support_weight": 1.65,
          "contradiction_weight": 1.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Lacosamide efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_lacosamide"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Lacosamide influences GABA release, involved in GABAergic pathway."
          ],
          "safety_risk": [
            "Skeptic highlights potential adverse effects that may reduce its therapeutic efficacy."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Need further evidence on Lacosamide's long-term safety and its risk profile."
        ]
      },
      {
        "hypothesis_id": "H3",
        "score": 0.62,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.65,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.6
        },
        "graph_signals": {
          "support_weight": 1.6,
          "contradiction_weight": 1.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Levetiracetam efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_levetiracetam"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Levetiracetam is known for modulating GABA, acting on GABA_A receptor."
          ],
          "safety_risk": [
            "Skeptic notes potential adverse effects that may compromise therapeutic benefits."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Further validation needed on long-term effects and safety profile."
        ]
      },
      {
        "hypothesis_id": "H4",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.7
        },
        "graph_signals": {
          "support_weight": 1.55,
          "contradiction_weight": 1.6,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Lamotrigine efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_lamotrigine"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Lamotrigine affects ion channels that interact with GABA pathways."
          ],
          "safety_risk": [
            "Skeptic indicates there may be risks that counteract its benefits."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Safety profile still requires adequate assessment."
        ]
      },
      {
        "hypothesis_id": "H5",
        "score": 0.58,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.55,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.7
        },
        "graph_signals": {
          "support_weight": 1.5,
          "contradiction_weight": 1.6,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Topiramate efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_topiramate"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Topiramate enhances GABA_A receptor functionality."
          ],
          "safety_risk": [
            "Skeptic highlights potential adverse reactions affecting its utility."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Further investigation is required regarding side effects."
        ]
      },
      {
        "hypothesis_id": "H6",
        "score": 0.8,
        "components": {
          "mechanism_fit": 0.85,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.75,
          "indication_plausibility": 0.75,
          "safety_risk": 0.2,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 1.9,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Valproate is a potent GABA_A receptor enhancer."
          ],
          "safety_risk": []
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.56,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.7
        },
        "graph_signals": {
          "support_weight": 1.4,
          "contradiction_weight": 1.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Zonisamide efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_zonisamide"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Zonisamide affects GABA signaling."
          ],
          "safety_risk": [
            "Skeptic raises potential adverse event risks that complicate its efficacy."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Insufficient long-term data on Zonisamide's safety."
        ]
      },
      {
        "hypothesis_id": "H8",
        "score": 0.54,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.7
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 1.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Rufinamide efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_rufinamide"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Rufinamide modulates GABA channels."
          ],
          "safety_risk": [
            "Skeptic notes adverse effects alignment that impedes efficacy."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Rufinamide's full safety profile requires more data."
        ]
      },
      {
        "hypothesis_id": "H9",
        "score": 0.52,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.45,
          "indication_plausibility": 0.45,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.8
        },
        "graph_signals": {
          "support_weight": 1.2,
          "contradiction_weight": 1.6,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Perampanel efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_perampanel"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Perampanel acts indirectly on GABA pathways."
          ],
          "safety_risk": [
            "Skeptic emphasizes existence of adverse reactions that could nullify benefits."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Lack of comprehensive safety assessment for Perampanel."
        ]
      },
      {
        "hypothesis_id": "H10",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.45,
          "indication_plausibility": 0.45,
          "safety_risk": 0.4,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.8
        },
        "graph_signals": {
          "support_weight": 1.0,
          "contradiction_weight": 1.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Carbamazepine efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_carbamazepine"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Carbamazepine interacts with GABA_A signaling."
          ],
          "safety_risk": [
            "Skeptic outlines possible side effects that could counteract its efficacy."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Inconsistencies in evidence regarding Carbamazepine's safety and efficacy."
        ]
      },
      {
        "hypothesis_id": "H11",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.45,
          "safety_risk": 0.4,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.8
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 1.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Eslicarbazepine efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_eslicarbazepine"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Eslicarbazepine has some action on GABA pathways."
          ],
          "safety_risk": [
            "Skeptic points to adverse effects that may jeopardize treatment outcomes."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Need better clarity on the risk-benefit ratio."
        ]
      },
      {
        "hypothesis_id": "H12",
        "score": 0.46,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.45,
          "safety_risk": 0.4,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.8
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 1.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Phenobarbital efficacy vs. adverse effects",
              "pro": [
                "claim_efficacy"
              ],
              "con": [
                "n_adv_phenobarbital"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Phenobarbital is believed to generally enhance GABA activity."
          ],
          "safety_risk": [
            "Skeptic underscores potential adverse events that could limit effectiveness."
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Further research is needed to fully outline its feasibility."
        ]
      }
    ],
    "ranking": [
      "H6",
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "delta_since_last_round": 0.06,
    "stop_decision": {
      "should_stop": false,
      "reasons": [
        "Δscore≥0.03"
      ]
    }
  }
}